3 unknown, 1 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Ge Zheng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia Chidamide, Cladribine - Acute Myeloid Leukemia | Phase 2 | Unknown | Ge Zheng | 31 | 2021-06-01 | 2022-04-29 |
| Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML Azacitidine, Lenalidomide - Acute Myeloid Leukemia in Remission | Phase 3 | Unknown | Ge Zheng | 60 | 2020-09-01 | 2022-03-24 |
| Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML Homoharringtonine, Azacitidine - Acute Myeloid Leukemia | Phase 2 | Unknown | Ge Zheng | 100 | 2019-12-01 | 2022-09-08 |
| Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma Lymphoma | Completed | Ge Zheng | 60 | 2018-07-01 | 2022-03-24 |
Leukemia, Myeloid, Acute (3) · Lymphoma (1)
Azacitidine (2) · Cladribine (1) · Homoharringtonine (1) · Lenalidomide (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1)
China (4)
Zheng Ge, M.D, Ph.D (3) · Zheng Ge (1)